|
Fig. 1.
Gtpbp2 interacts with Smad proteins. (A) Schematic representation of Gtpbp2 and its conserved domains. Partial-length proteins isolated by yeast two-hybrid (Y2H) or constructed for interaction assays (δC and δN) are delineated by horizontal lines. Symbols A and B indicate the position of ATG start codons in the corresponding two isoforms of human Gtpbp2 protein. (B) Flag–Smad1 construct was co-expressed with HA–Gtpbp2B in Hek293T cells, lysed, immunoprecipitated (IP) with Flag–agarose beads, and analyzed by western blot (WB) using α-HA-HRP and α-flag M2 antibodies. Lower panel shows Gtpbp2b levels in total cell lysates (TCL); top two panels show co-immunoprecipitated proteins. (C) Xenopus Gtpbp1, Gtpbp2 and Smurf1, or GFP was individually translated in vitro in rabbit reticulocyte lysates, and labeled with 35S-Methionine. GST and GST–Smad1 proteins were expressed in and purified from E. coli. Purified GST-tagged proteins were incubated with each in vitro translated protein and pulled down by GST beads. Gtpbp2 interacts with GST–Smad1 in vitro whereas Gtpbp1 does not. Xenopus Smurf1 was used as a positive control and GFP as a negative control. (D) Flag–Smad1, Flag–MH1 domain, and Flag–MH2 domain constructs (all Xenopus) were co-expressed with HA–Gtpbp2b and analyzed as in panel (B). (E) HA-tagged Gtpbp2b (full-length), δN-Gtpbp2b and δC-Gtpbp2b were co-expressed with Flag-tagged Xenopus Smad1 in Hek293T cells and analyzed by IP as in panel (B).
|
|
Fig. 2.
Temporal and tissue specific expression of Gtpbp2 during Xenopus laevis development. (A) Maternal gtpbp2 transcripts were detected primarily in the animal pole at blastula stages (in sectioned stage 7 embryos). (B) At the onset of gastrulation (stage 10) gtpbp2 is expressed in the inner layer of ectoderm and mesoderm. Arrow shows dorsal blastopore lip. (C) At swimming tadpole stage (stage 35) gtpbp2 is strongly expressed in the somites, as well as in the brain, branchial arches, and ventral blood islands (VBI). Arrow shows VBI-specific expression of gtpbp2. (D) Semi-quantitative RT-PCR showing gtpbp2 levels across stages. The gtpbp2 signal significantly diminishes as gastrulation progresses, but is re-expressed at tadpole stages.
|
|
Fig. 3.
Gtpbp2 is required for BMP signaling in Xenopus animal cap tissue culture. (A) Two non-overlapping morpholinos are designed against the start site of gtpbp2 mRNA (M1 and M2), along with a control morpholino which has 5 mismatches to M1 binding site. Western blot shows Gtpbp2 morpholinos, M1 and M2, block translation of a C-terminally myc-tagged partial Gtpbp2 reporter construct injected into X. laevis embryos whereas a 5-mismatch to M1 control morpholino does not interfere with the expression of this reporter construct. A gtpbp2–myc mRNA (1 ng) harboring the 5′UTR and first few amino acids preceding the conserved domains of Gtpbp2 was coinjected with gfp mRNA (1 ng) and the morpholinos. Gtpbp2–myc protein levels were assayed by western blotting using anti-myc and anti-GFP antibodies, in embryo lysates harvested at mid-gastrulation (stage 11). (B) Loss of Gtpbp2 inhibited BMP signaling. Embryos were injected at two-cell stage with 500 pg bmp4 mRNA, and 20 ng M1, or 40 ng M2, or 40 ng 5 mismatched-to-M1 morpholino (mis). Animal cap tissue was dissected at Stage 8, and cultured to Stage 11. BMP responsive genes ventx1.1 (vent1), wnt8a (wnt8), evx1 (xhox3) were assayed by quantitative RT-PCR (qPCR). (C) Co-injection of 100–400 ng of a Gtpbp2 mRNA without morpholino target sites along with M1 morpholino restores BMP signaling in cultured animal cap explants. BMP signaling was assayed by the response of BMP target genes, by qPCR. (D) BMP signaling was assayed with a BMP/Smad1-responsive vent2:luciferase reporter in animal caps. This reporter is significantly expressed when injected into animal caps with control morpholino, but including 20 or 40 ng of Gtpbp2 morpholino M1 reduces Vent2–luciferase reporter activity to about half that of the control level (standard error indicated). Endogenous BMP response genes: evx (Xhox3), ventx1.1 (vent1) and wnt8a (wnt8). Assays in (B, C) performed on two or more biological replicates.
|
|
Fig. 4.
Gtpbp2 is required for embryonic ventrolateral mesoderm patterning. (A) Gtpbp2 is required for posterior tissue development. Diagram depicts the way 4-cell X. laevis embryos were injected. Colored figure is shown to illustrate how dorsal (D) and ventrally-fated blastomeres (V) are identified and injected. Dorsal is the lighter pigmented half. Grayscale figure is the lateral view of the embryo. Embryos were injected with 30 ng Gtpbp2 morpholino into the two ventral blastomeres at the 4-cell stage, placed in the ventral marginal zone (VMZ) and cultured to stage 35. Loss of Gtpbp2 leads to the complete loss of tail and posterior tissues. (B) Morpholino knockdown of Gtpbp2 results in a severe reduction of post (xpo), wnt8, and myod1 (myf3) expression. Vent1 expression domain is more restricted to ventral tissues compared to controls. Embryos were injected with 30 ng Gtpbp2 morpholino at 4 cell stage targeting the VMZ; the future posterior ventral tissues. (C) Gtpbp2 is not required for mesendodermal induction. Sox17a, mixer, and mix1 expressions are not affected. Embryos were injected bilaterally with 40 ng Gtpbp2 morpholino at the 2-cell stage. Three independent sets of at least 20 embryos were analyzed in B and C, resulting in similar effects on marker gene expression.
|
|
Fig. 5.
Gtpbp2 is required for embryonic ventrolateral mesoderm patterning gene expression. Quantitative RT-PCR (qPCR) analysis of gene expression in control and Gtpbp2 morphant embryos. (A) Early gastrulation (stage 10.25) and (B) mid-gastrulation (stage 11), embryos have severely decreased expression levels of ventral lateral genes post (xpo) andevx1 (xhox3), but mild or no change in vent1 or vent2 expression. Ventral genes; ventx1.1 (vent1), wnt8a (wnt8), evx1 (xhox3) were assayed by qPCR. Relative expression is normalized to control morpholino-injected embryos. Black bars indicate standard error from triplicate biological replicates.
|
|
Fig. 6.
Gtpbp2 subcellular localization and induction of BMP target genes. (A) mCherry-tagged Xenopus Gtpbp2a mRNA (2 ng), co-injected with a membrane-localized GFP (mem-GFP) mRNA (10 pg), and costained with DAPI, shows nuclear and cytoplasmic localization in gastrula stage 11 animal cap cells; (i) mCherry–Gtpbp2 signal only, (ii) merged signals for mCherry–Gtpbp2b, mem-GFP and DAPI. (B) X. laevis Gtpbp2b can induce BMP marker genes evx1, wnt8a, vent2.2 in animal caps. gtpbp2b mRNA was injected at increasing doses (0.2 ng, 1 ng, and 4 ng) into the animal pole of two cells stage embryos, animal caps were excised at stage 8, and cultured to stage 11 before gel-based RT-PCR with primers to indicated genes (otx as positive control for RT and loading). (C) qPCR analysis of the BMP targets vent1.2,wnt8, and evx1 in animal caps injected at the 2 cell stage with increasing doses of gtpbp2a or gtpbp2b mRNA, excised at the 8 cells stage, and cultured to stage 11. (D) Comparison of accumulation of HA-tagged X. laevis Gtpbp2a versus Gtpbp2b isoforms in embryos injected with increasing doses of mRNA at the 2- cell stage and lysed at stage 11 for western blotting using an anti-HA antibody.
|
|
Fig. S1.
Gtpbp2 isoforms and N-termini in vertebrates. (A) Comparison of genomic organization of the Human Gtpbp2 alternative splice isoforms a and b. (B) An alignment of the N-termini of Gtpbp2 orthologs from a variety of vertebrates (Xenopus laevis, Xenopus tropicalis, Mus musculus, Homo sapiens isoform A and isoform B, Gallus gallus, Danio rerio), as well as the invetebrate nematode Caenorhabditis elegans.
|
|
Fig. S2.
Analysis of Gtpbp2 temporal expression by quantitative RT-PCR and whole mount in situ hybridization. (A) Gtpbp2 transcripts were quantified across developmental stages, with expression levels normalized to the housekeeping gene ornithine decarboxylase (odc) and shown in arbitrary units by setting the expression level of a fertilized egg (Stage1) to 1. Gtpbp2 expression significantly decreases during gastrulation. Stage 11 corresponds to mid-gastrulation and stage 12 corresponds to late gastrulation. (B) Whole mount in situ hybridization on staged embryos, confirming the localization of gtpbp2 transcripts to the animal pole of the egg and early cleaving 4-cell blastula. Neurula stage expression is weak but enriched in neural folds at early (stage 15) and late (stage 20) neurula. Stage 25, early tailbud tadpole expression of gtpbp2 is most prominent in the somites (s) and eye (e), with enrichment in the central nervous system (cns). A sense strand RNA in situ probe was hybridized to the tadpole at top, and an antisense probe was hybridized to the tadpole at bottom.
|
|
Fig. S3.
Rescue of morphant body axis length, and effects of Gtpbp2 knockdown on the Xenopus ectoderm. Embryos were injected in 2 ventral blastomeres at the 4-cell stage with Gtpbp2 M1 morpholino (bp2 M1; 15 ng total) or that morpholino plus a rescue gtpbp2 mRNA ha-5mis-bp2a (1.5 ng total), which contains 5 mismatches to the M1 morpholino at the target sequence. (A) Embryos were cultured until stage 36 and then fixed and imaged. The panels represent the least affected four embryos from the morphant (left) or rescue (right). (B) The anterior/posterior length of all morphant or rescue embryos was measured relative to the breadth of a wildtype embryo and presented in a boxplot (left). Statistical testing was conducted using R (3.0.2). Welch Two Samples t-test, p-value=0.000836, mean of morphant 1.70, (n=19), mean of rescue 2.16 (n=18). C. Gtpbp2 morphant animal caps show a decrease in expression of epidermal markers (cytokeratin; xk81a1), but no increase in markers of cement gland (ag1) or neural tissue (ncam1,sox2). Animal caps were treated with control MO (C), Gtpbp2 MO1 (M1) or MO2 (M2), with gene expression values first normalized to ODC levels, with keratin plotted relative to the control cap level, and neural markers plotted relative to wildtype embryo levels.
|
|
Fig. S4.
Phylogenetic analysisof large GTPase superfamily. Phylogenetic trees of Gtpbp and elongation-factor-like proteins generated from a maximum likelihood analysis, using the Phyml-alrt program (JTT model, fixed sites, Gamma=1). Branch labels represent the approximate likelihood ratio test chi-square parameter. Species evaluated are indicated. Dataset available on request.
|
|
Fig. S5.
Gtpbp2 morpholino does not affect Smad1 protein levels, Smad1 C-terminal phosphorylation, Smad1/Smad4 complex formation, or Smad1 localization. (A) Top row of panels: far left shows representative western blot detecting endogenous Smad1 or activated, C-terminal phosopho-Smad1 (pSmad1) levels in embryos injected at the two-cell stage with Gtpbp2 M1 morpholino; middle and right panels show measurements of Smad1 and C-terminal phospho-Smad1 (pSmad1) levels, relative to Beta Tubulin protein (B-tub), from three separate biological replicates, with standard error bars. Quantitation was with an Odyssey Infrared Imager (LI-COR, Inc.). (B) Immunoprecipitation of Myc-tagged Smad4 in Gtpbp2 morphant embryos shows no increase or decrease in the levels of co-immunoprecipitated Smad1 versus controls, while embryos injected with activated Bmpr1a (alk3) mRNA show an expected increase in Smad4/Smad1 complexes. (C) Fluorescent GFP–Smad1 shows no change in subcellular localization in animal cap cells co-injected at the 2-cell stage with either control (cMO) or Gtpbp2 M1 morpholinos. GFP fluorescence was evaluated on animal cap cells cut at stage 8, dissociated in Ca2+ free medium, then cultured on fibronectin coated slides and photographed when sibling intact embryos reached gastrula stage 10. (D) mCherry-tagged Xenopus Gtpbp2 proteins corresponding to isoforms a and b were expressed in cultured COS cells. Gtpbp2b was localized to the nucleus (left), whereas Gtpbp2a was primarily located in the cytoplasm at low levels (middle) but could enter the nucleus when a larger amount of DNA was transfected. Upper, black and white panels show mCherry–Gtpbp2 cell fluorescence; lower color panels show mCherry–Gtpbp2 signal merged with with DAPI signal. (E) When co-transfected into COS cells, HA–Gtpbp2b and Myc–Smad1 are co-localized in the nucleus, with significant co-localization to distinct subnuclear foci.
|
|
Fig. S6.
The Gtpbp2 isoforms can both localize to nuclei independent of cell contact. Either mCherry-tagged Gtpbp2a or Gtpbp2a mRNA (1 ng) was injected into embryos at 2-cell stage, and animal caps were excised from the embryos, dissociated, and grown on fibronectin coated slides as described in Simeoni and Gurdon (2007). Red fluorescence and DAPI staining were imaged with a Zeiss microscope and merged in the lower panels.
|
|
gtpbp2 (GTP binding protein 2) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 1, horizontal view, animal up.
|
|
gtpbp2 (GTP binding protein 2) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 20, anterior view, dorsal up.
|
|
gtpbp2 (GTP binding protein 2) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 25, lateral view, anterior right, dorsal up.
|
|
gtpbp2 (GTP binding protein 2) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 35, lateral view, anterior left, dorsal up.
|